APIMEDS PHARMACEUTICALS US I

Q1 2026 13F Holders

Symbol
APUS
CUSIP
03771D102
Type
Equity
Class
COM SHS
Num filings
6
Total reported value, excl. options
$803 k
Manager Report Date Value ($000) Shares Option Type